By Silke Erbeck, Head of Supply Chain & Project Management, Lonza
In today’s drug development landscape, complexity is on the rise, and not just because of the advanced capabilities needed to synthesize the next generation of chemical compounds. Drug development programs are becoming more complex, often spanning global networks and multiple external providers or contract development & manufacturing organizations (CDMOs). Even working with a single CDMO can require coordination between production sites located on different continents. Silke Erbeck, Head of Supply Chain & Project Management, Lonza Small Molecules, shares her insights into steps CDMOs can take to streamline project management to benefit small and emerging biotech companies they work with.